<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04778735</url>
  </required_header>
  <id_info>
    <org_study_id>MemorialBahcelievler</org_study_id>
    <nct_id>NCT04778735</nct_id>
  </id_info>
  <brief_title>Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation</brief_title>
  <official_title>Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation: A Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Bahçelievler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Bahçelievler Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Department of Organ Transplantation in Memorial Hospitals has started Pediatric Liver&#xD;
      Transplantation Program in 2016. As of the end of 2020, we have performed 169 pediatric liver&#xD;
      transplantation. The aim of this study is to investigate the overall mortality, morbidity and&#xD;
      risk factors for adverse outcomes in pediatric liver transplantation. The patients' records&#xD;
      will be retrospectively scanned and the data will be gathered.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2021</start_date>
  <completion_date type="Anticipated">April 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival</measure>
    <time_frame>1 minutes</time_frame>
    <description>Patient and graft survival ratios</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perioperative informations</measure>
    <time_frame>5 minutes</time_frame>
    <description>Perioperative informations such as blood loss and blood transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Tests</measure>
    <time_frame>15 minutes</time_frame>
    <description>Blood markers that evaluated at the pre and post operative phase such as Internation Normalized Ratio (INR), total bilirubin and albumin values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>5 minutes</time_frame>
    <description>Postoperative Complications such as sepsis or hepatic artery thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative informations</measure>
    <time_frame>10 minutes</time_frame>
    <description>Postoperative informations such as initial hospital stay, ICU stay or mechanic ventilation time</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">169</enrollment>
  <condition>Liver Transplantation</condition>
  <condition>Liver Diseases</condition>
  <condition>Biliary Atresia</condition>
  <condition>Morbidity;Infant</condition>
  <condition>Mortality</condition>
  <arm_group>
    <arm_group_label>Pediatric Patients with Liver Transplantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Liver Transplantation</intervention_name>
    <description>Liver Transplantation is performed under spesific conditions to increase the life time of patients with liver diseases.</description>
    <arm_group_label>Pediatric Patients with Liver Transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients with liver transplantation (&lt;18 years)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with incomplete medical records will be excluded&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kamil Yalçın Polat, Prof.</last_name>
    <phone>(0212) 408 45 45</phone>
    <phone_ext>4212</phone_ext>
    <email>kamilypolat@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Memorial Bahçelievler Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34700</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamil Yalçın Polat, Prof</last_name>
      <phone>(0212) 408 45 45</phone>
      <phone_ext>4212</phone_ext>
      <email>kamilypolat@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 24, 2021</study_first_submitted>
  <study_first_submitted_qc>February 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>February 28, 2021</last_update_submitted>
  <last_update_submitted_qc>February 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Memorial Bahçelievler Hospital</investigator_affiliation>
    <investigator_full_name>Kamil Yalçın Polat</investigator_full_name>
    <investigator_title>Prof.Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Diseases</mesh_term>
    <mesh_term>Biliary Atresia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

